Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 67,026 shares at $33.38 ($2.2M) on 2024-12-02, disclosed to the SEC on 2024-12-03.
Scheduled sale ($2.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.38 | 33,513 | $1.1M | 50.0% |
| 2 | $33.38 | 33,513 | $1.1M | 50.0% |
| Total | $33.38 avg | 67,026 | $2.2M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |